These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33916905)

  • 1. The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons.
    Wu QW; Kapfhammer JP
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
    Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
    Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA targeting with CRISPR-Cas13.
    Abudayyeh OO; Gootenberg JS; Essletzbichler P; Han S; Joung J; Belanto JJ; Verdine V; Cox DBT; Kellner MJ; Regev A; Lander ES; Voytas DF; Ting AY; Zhang F
    Nature; 2017 Oct; 550(7675):280-284. PubMed ID: 28976959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bacterial Enzyme RfxCas13d Is Less Neurotoxic Than PspCas13b and Could Be a Promising RNA Editing and Interference Tool in the Nervous System.
    Wu QW; Kapfhammer JP
    Brain Sci; 2021 Aug; 11(8):. PubMed ID: 34439673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures, mechanisms and applications of RNA-centric CRISPR-Cas13.
    Yang H; Patel DJ
    Nat Chem Biol; 2024 Jun; 20(6):673-688. PubMed ID: 38702571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-Targeting CRISPR-Cas Systems and Their Applications.
    Burmistrz M; Krakowski K; Krawczyk-Balska A
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmable Inhibition and Detection of RNA Viruses Using Cas13.
    Freije CA; Myhrvold C; Boehm CK; Lin AE; Welch NL; Carter A; Metsky HC; Luo CY; Abudayyeh OO; Gootenberg JS; Yozwiak NL; Zhang F; Sabeti PC
    Mol Cell; 2019 Dec; 76(5):826-837.e11. PubMed ID: 31607545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.
    Meeske AJ; Nakandakari-Higa S; Marraffini LA
    Nature; 2019 Jun; 570(7760):241-245. PubMed ID: 31142834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of CRISPR technology to high content screening in primary neurons.
    Callif BL; Maunze B; Krueger NL; Simpson MT; Blackmore MG
    Mol Cell Neurosci; 2017 Apr; 80():170-179. PubMed ID: 28110021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary - CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19.
    Zaami S; Piergentili R; Marinelli E; Montanari Vergallo G
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1752-1761. PubMed ID: 33629345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
    Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
    Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.
    Méndez-Mancilla A; Wessels HH; Legut M; Kadina A; Mabuchi M; Walker J; Robb GB; Holden K; Sanjana NE
    Cell Chem Biol; 2022 Feb; 29(2):321-327.e4. PubMed ID: 34343484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila.
    Huynh N; Depner N; Larson R; King-Jones K
    Genome Biol; 2020 Nov; 21(1):279. PubMed ID: 33203452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13.
    Burris BJD; Molina Vargas AM; Park BJ; O'Connell MR
    Methods; 2022 Oct; 206():58-68. PubMed ID: 35987443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, classification and application of the CPISPR-Cas13 system.
    Nie X; Wang D; Pan Y; Hua Y; Lü P; Yang Y
    Technol Health Care; 2024; 32(2):525-544. PubMed ID: 37545273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alleviation of neurological disease by RNA editing.
    Zhang S; Chen L; Zhang Y; Fang D
    Methods; 2021 Oct; 194():94-99. PubMed ID: 33933604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas RNA Targeting Using Transient Cas13a Expression in Nicotiana benthamiana.
    Sharma V; Zheng W; Huang J; Cook DE
    Methods Mol Biol; 2021; 2170():1-18. PubMed ID: 32797447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector.
    Jain I; Kolesnik M; Kuznedelov K; Minakhin L; Morozova N; Shiriaeva A; Kirillov A; Medvedeva S; Livenskyi A; Kazieva L; Makarova KS; Koonin EV; Borukhov S; Severinov K; Semenova E
    Sci Adv; 2024 Apr; 10(17):eadl0164. PubMed ID: 38657076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Knockdown the expression of ku70 and lig4 in HEK293T cells by CRISPR/Cas13 system].
    Wang H; Li G; Huang G; Li Z; Zheng E; Xu Z; Yang H; Wu Z; Zhang X; Liu D
    Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1414-1421. PubMed ID: 32748599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.